VJHemOnc is committed to improving our service to you

EBMT 2020 | NK-CAR immunotherapy development over the past 12 months

VJHemOnc is committed to improving our service to you

Evelyn Ullrich

Evelyn Ullrich, MD, PhD, Goethe University Frankfurt, Frankfurt, Germany, talks on the development of NK-CAR immunotherapy over the past 12 months and important routes for further study. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter